Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Oct;9(10):3469-3472.
doi: 10.21037/jtd.2017.09.15.

Molecular mechanisms of pathological tumor transformation and their clinical implications: predictors of pulmonary adenocarcinoma transformation into small cell carcinoma

Affiliations
Editorial

Molecular mechanisms of pathological tumor transformation and their clinical implications: predictors of pulmonary adenocarcinoma transformation into small cell carcinoma

Maria-Rosa Ghigna et al. J Thorac Dis. 2017 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

References

    1. Lee JK, Lee J, Kim S, et al. Clonal history and genetic predictors of transformation into small-cell carcinomas from lung adenocarcinomas. J Clin Oncol 2017;35:3065-74. - PubMed
    1. Asano N, Yoshida A, Mitani S, et al. Frequent amplification of receptor tyrosine kinase genes in welldifferentiated/ dedifferentiated liposarcoma. Oncotarget 2017;8:12941-52. - PMC - PubMed
    1. Rossi D. Richter's syndrome: Novel and promising therapeutic alternatives. Best Pract Res Clin Haematol 2016;29:30-9. 10.1016/j.beha.2016.08.006 - DOI - PubMed
    1. Hehlmann R, Saußele S, Voskanyan A, et al. Management of CML-blast crisis. Best Pract Res Clin Haematol 2016;29:295-307. 10.1016/j.beha.2016.10.005 - DOI - PubMed
    1. Ogata H, Okamoto I, Yoshimoto G, et al. Chronic myelomonocytic leukemia blast crisis in a patient with advanced non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors. Respir Investig 2017;55:181-3. 10.1016/j.resinv.2016.12.002 - DOI - PubMed

LinkOut - more resources